These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25407022)

  • 1. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
    Tinholt M; Viken MK; Dahm AE; Vollan HK; Sahlberg KK; Garred O; Børresen-Dale AL; Jacobsen AF; Kristensen V; Bukholm I; Kåresen R; Schlichting E; Skretting G; Lie BA; Sandset PM; Iversen N
    BMC Cancer; 2014 Nov; 14():845. PubMed ID: 25407022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.
    Segers O; Simioni P; Tormene D; Castoldi E
    Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation as an intermediate phenotype for venous thrombosis.
    Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
    Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
    Tinholt M; Vollan HK; Sahlberg KK; Jernström S; Kaveh F; Lingjærde OC; Kåresen R; Sauer T; Kristensen V; Børresen-Dale AL; Sandset PM; Iversen N
    Breast Cancer Res; 2015 Mar; 17(1):44. PubMed ID: 25882602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study.
    Tinholt M; Garred Ø; Borgen E; Beraki E; Schlichting E; Kristensen V; Sahlberg KK; Iversen N
    J Thromb Haemost; 2018 Jul; 16(7):1347-1356. PubMed ID: 29766637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of acquired activated protein C resistance and D-dimer in breast cancer.
    Tinholt M; Sandset PM; Mowinckel MC; Garred Ø; Sahlberg KK; Kristensen VN; Børresen-Dale AL; Jacobsen AF; Skretting G; Iversen N
    Thromb Res; 2016 Sep; 145():78-83. PubMed ID: 27505249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
    Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM
    Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The A6936G polymorphism of the endothelial protein C receptor gene is associated with the risk of unexplained foetal loss in Mediterranean European couples.
    Cochery-Nouvellon E; Chauleur C; Demattei C; Mercier E; Fabbro-Peray P; Marès P; Mismetti P; Lissalde-Lavigne G; Gris JC
    Thromb Haemost; 2009 Oct; 102(4):656-67. PubMed ID: 19806250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
    Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
    Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
    Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
    Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy.
    Galanaud JP; Cochery-Nouvellon E; Alonso S; Chauleur C; Mercier E; Lissalde-Lavigne G; Fabbro-Peray P; Reny JL; Mares P; Dauzat M; Quere I; Gris JC
    J Thromb Haemost; 2010 Apr; 8(4):707-13. PubMed ID: 20141580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of two haplotypes of the human endothelial protein C receptor gene.
    Medina P; Navarro S; Bonet E; Martos L; Estellés A; Bertina RM; Vos HL; España F
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):684-90. PubMed ID: 24436369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study.
    Bergrem A; Dahm AE; Jacobsen AF; Sandvik L; Sandset PM
    Thromb Haemost; 2012 Dec; 108(6):1165-71. PubMed ID: 23015030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
    Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
    Kim KY; Han W; Noh DY; Kang D; Kwack K
    Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of endothelial protein C receptor haplotypes, factor V Leiden and recurrent first trimester pregnancy loss.
    Hopmeier P; Puehringer H; van Trotsenburg M; Atamaniuk J; Oberkanins C; Dossenbach-Glaninger A
    Clin Biochem; 2008 Aug; 41(12):1022-4. PubMed ID: 18539144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
    Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
    Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
    Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.